Liquid Biopsy in Head and Neck Cancer
Genetic Profiling by Liquid Biopsy for Initial Characterization and Response Monitoring of Head and Neck Squamous Cell Carcinoma (HNSCC)
Sponsor: Turku University Hospital
Listed as NCT03926468, this observational or N/A phase trial focuses on Head and Neck Squamous Cell Carcinoma and remains ongoing. Sponsored by Turku University Hospital, it has been updated 8 times since 2019, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Feb 2023 — Jul 2024 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
-
Dec 2021 — Feb 2023 [monthly]
Not Yet Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Not Yet Recruiting
▶ Show 3 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting
-
Jul 2019 — Nov 2020 [monthly]
Not Yet Recruiting
-
May 2019 — Jul 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Turku University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .